AnnJi Pharmaceutical Past Earnings Performance
Past criteria checks 0/6
AnnJi Pharmaceutical's earnings have been declining at an average annual rate of -29.2%, while the Pharmaceuticals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 152.8% per year.
Key information
-29.2%
Earnings growth rate
-2.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 18.5% |
| Revenue growth rate | 152.8% |
| Return on equity | -45.1% |
| Net Margin | -200.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How AnnJi Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 182 | -365 | 46 | 307 |
| 31 Mar 24 | 163 | -347 | 43 | 277 |
| 31 Dec 23 | 144 | -329 | 40 | 247 |
| 31 Dec 22 | 2 | -237 | 18 | 223 |
| 31 Dec 21 | 1 | -199 | 19 | 184 |
Quality Earnings: 7754 is currently unprofitable.
Growing Profit Margin: 7754 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 7754's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare 7754's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 7754 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.2%).
Return on Equity
High ROE: 7754 has a negative Return on Equity (-45.1%), as it is currently unprofitable.